In September 2025, Smackover Lithium, a joint venture between Standard Lithium and Equinor, announced a maiden inferred resource for its Franklin Project in northeast Texas, reporting the highest lithium-in-brine concentration ever found in North America and outlining significant brine mineral leasing activity and multi-phase production ambitions. This initiative reflects Equinor’s expanding efforts to diversify into U.S. critical minerals, with the maiden resource including lithium, potash, and bromide, and supports long-term plans for large-scale lithium chemical production in Texas. We'll examine how the U.K. government’s new North Sea restrictions could influence Equinor’s future project pipeline and business outlook. AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Equinor Investment Narrative Recap To own a piece of Equinor, you need conviction in the company’s ability to deliver stable returns from its core oil and gas business while making successful bets on diversification into critical minerals and renewables. The Smackover Lithium maiden resource report signals long-term ambitions in U.S. lithium but does not materially shift Equinor’s most important short-term catalyst, strong performance and contract stability in its core upstream production, nor does it change the immediate risk tied to declining North Sea production and regulatory challenges. Among recent announcements, the long-term gas supply agreement with BASF (signed July 2025) stands out as directly relevant to the stability of Equinor’s earnings. This contract provides visibility and revenue support to the gas business, underpinning the company’s efforts to mitigate the effects of field maturation and address production risk in traditional markets while pursuing new opportunities like lithium in the U.S. Yet, in contrast to these strengths, the complexities introduced by North Sea regulatory changes present a material factor that investors should keep in mind... Read the full narrative on Equinor (it's free!) Equinor's outlook projects $90.2 billion in revenue and $7.6 billion in earnings by 2028. This implies a 5.4% annual decline in revenue and a $0.6 billion decrease in earnings from the current $8.2 billion. Uncover how Equinor's forecasts yield a NOK250.44 fair value, in line with its current price. Exploring Other PerspectivesOB:EQNR Community Fair Values as at Oct 2025 Fifteen different Simply Wall St Community estimates place Equinor’s fair value between NOK194.52 and NOK574.78. The recent focus on contract stability and regulatory pressure shows why views can vary so widely, consider exploring the range of insights for a fuller picture. Story Continues Explore 15 other fair value estimates on Equinor - why the stock might be worth over 2x more than the current price! Build Your Own Equinor Narrative Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your Equinor research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision. Our free Equinor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Equinor's overall financial health at a glance. No Opportunity In Equinor? Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay: Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 33 best rare earth metal stocks of the very few that mine this essential strategic resource. We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Outshine the giants: these 25 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include EQNR.ob. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Did Smackover Lithium's Record Texas Find Just Shift Equinor's (OB:EQNR) U.S. Growth Strategy?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...